![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The comp... Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug development company. It is engaged in utilizing a novel technology that achieves systemic delivery for target-specific protein inhibition for any gene product that is over-expressed in disease. The company's lead drug candidate, prexigebersen, is in the efficacy portion of Phase 2 clinical trial for acute myeloid leukemia (AML) in combination with low-dose cytarabine (LDAC) and combination with decitabine. Its other drugs are BP1002 and BP1003. Show more
Marks Meaningful Progress Across Key Clinical Trials in Multiple Cancer Indications Completes Development of Oncology Molecular Biomarkers and Prepares for Preclinical Obesity Studies HOUSTON...
HOUSTON, June 14, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilizeยฎ liposomal delivery and antisense technology to...
HOUSTON, June 05, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc. (NASDAQ:BPTH) (โBio-Pathโ or the โCompanyโ), a biotechnology company leveraging its proprietary DNAbilizeยฎ liposomal delivery...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.04 | -2.20994475138 | 1.81 | 1.8399 | 1.69 | 33952 | 1.76954842 | CS |
4 | -0.2 | -10.152284264 | 1.97 | 2.13 | 1.591 | 105809 | 1.82822428 | CS |
12 | -0.78 | -30.5882352941 | 2.55 | 4.55 | 1.591 | 1237517 | 3.0606947 | CS |
26 | -7.41 | -80.7189542484 | 9.18 | 9.9875 | 1.591 | 1301231 | 3.76984874 | CS |
52 | -17.432 | -90.7822101864 | 19.202 | 23 | 1.591 | 1414080 | 8.98402584 | CS |
156 | -128.23 | -98.6384615385 | 130 | 172.398 | 1.591 | 601636 | 31.28772136 | CS |
260 | -280.23 | -99.3723404255 | 282 | 486.8 | 1.591 | 572838 | 80.38728167 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions